| Gordon Y Lee, PA-C | |
|
500 San Pablo Ave, Albany, CA 94706-1103 | |
| (510) 204-8130 | |
| (510) 524-0861 |
| Full Name | Gordon Y Lee |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 15 Years |
| Location | 500 San Pablo Ave, Albany, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033432604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA20598 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alta Bates Summit Medical Center - Alta Bates Camp | Berkeley, CA | Hospital |
| Alta Bates Summit Medical Center | Oakland, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.
Experimental genetic techniques may one day provide plastic and reconstructive surgeons with an invaluable tool-the ability to promote growth of the patient's own tissues for reconstructive surgery.
Serrated colorectal polyps include the subgroups hyperplastic polyps, sessile serrated polyps (also called sessile serrated adenomas), and serrated adenomas. Recent studies have found that serrated polyps share molecular features with a subgroup of colon cancers, leading to the hypothesis that serrated polyps can be precursors of cancer through a hyperplastic polyp to serrated adenoma to cancer sequence.
According to a new study now available online, and to be published in an upcoming issue of the Journal of Critical Care, bedside testing for a blood biomarker called neutrophil gelatinase-associated lipocalin (NGAL) in patients being admitted to the intensive care unit can help to identify patients at risk for acute kidney injury (AKI).
St. Jude Medical, Inc. (NYSE: STJ) today announced the first use of the PressureWire™ Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. This first-to-market technology helps interventional cardiologists better determine the ideal treatment option for their patients during coronary interventions, such as stent procedures.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gordon Y Lee, PA-C 500 San Pablo Ave, Albany, CA 94706-1103 Ph: (510) 204-8130 | Gordon Y Lee, PA-C 500 San Pablo Ave, Albany, CA 94706-1103 Ph: (510) 204-8130 |
News Archive
GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.
Experimental genetic techniques may one day provide plastic and reconstructive surgeons with an invaluable tool-the ability to promote growth of the patient's own tissues for reconstructive surgery.
Serrated colorectal polyps include the subgroups hyperplastic polyps, sessile serrated polyps (also called sessile serrated adenomas), and serrated adenomas. Recent studies have found that serrated polyps share molecular features with a subgroup of colon cancers, leading to the hypothesis that serrated polyps can be precursors of cancer through a hyperplastic polyp to serrated adenoma to cancer sequence.
According to a new study now available online, and to be published in an upcoming issue of the Journal of Critical Care, bedside testing for a blood biomarker called neutrophil gelatinase-associated lipocalin (NGAL) in patients being admitted to the intensive care unit can help to identify patients at risk for acute kidney injury (AKI).
St. Jude Medical, Inc. (NYSE: STJ) today announced the first use of the PressureWire™ Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. This first-to-market technology helps interventional cardiologists better determine the ideal treatment option for their patients during coronary interventions, such as stent procedures.
› Verified 4 days ago
Sarah Jean Gardner, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 San Pablo Ave, Albany, CA 94706 Phone: 510-204-8130 Fax: 510-506-7726 | |
Christine Ciavarella, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 405 Kains Ave Ste 205, Albany, CA 94706 Phone: 510-524-3117 Fax: 510-524-4049 | |
Zoe Kritikos, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1065 Peralta Ave, Albany, CA 94706 Phone: 510-384-8506 |